Tag: Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc. ($APLS) Locks in $300M from Sobi for Aspaveli Royalties
Apellis Pharmaceuticals, Inc. (APLS) has entered a capped royalty purchase agreement with Sobi. The deal allows Apellis to receive up to $300 million in...